---
$id: https://graph.org.ai/products/commodity/51272114
$type: Product
source: UNSPSC
code: "51272114"
title: "Parethoxycaine hydrochloride"
class: "51272100"
classTitle: "Anaesthetic benzoates"
family: "51270000"
familyTitle: "Anaesthetic drugs and related adjuncts and analeptics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Parethoxycaine hydrochloride

**UNSPSC Code**: 51272114
**Class**: [Anaesthetic benzoates](Anaesthetic benzoates.mdx)
**Family**: [Anaesthetic drugs and related adjuncts and analeptics](../Anaesthetic drugs and related adjuncts and analeptics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anesthetic agent with the molecular formula C15H23NO3.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 414P5USJ7F, chemically known as benzoic acid, p-ethoxy-, 2-(diethylamino)ethyl ester, hydrochloride but more generally known as parethoxycaine hydrochloride, which bears US NIH Compound Identifier 8694. European Medicines Agency schedules Parethoxycaine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14777MIG. Most nations, for tariff and trade purposes, schedule parethoxycaine hydrochloride under HS 29221980 and SITC 51461. As of Q4 2014, PARETHOXYCAINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Parethoxycaine hydrochloride bears US NLM identifiers UMLS ID C2825614 and NCI Concept Code C81398. SMILES: CCN(CC)CCOC(=O)C1CCC(CC1)OCC.CL.

